FR2975595B1 - Utilisation de la guanosine comme agent anti-irritant. - Google Patents

Utilisation de la guanosine comme agent anti-irritant.

Info

Publication number
FR2975595B1
FR2975595B1 FR1154504A FR1154504A FR2975595B1 FR 2975595 B1 FR2975595 B1 FR 2975595B1 FR 1154504 A FR1154504 A FR 1154504A FR 1154504 A FR1154504 A FR 1154504A FR 2975595 B1 FR2975595 B1 FR 2975595B1
Authority
FR
France
Prior art keywords
guanosine
active agent
skin
cosmetic
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1154504A
Other languages
English (en)
Other versions
FR2975595A1 (fr
Inventor
Julien Laboureau
Carine Poumes-Ballihaut
Yann Mahe
Marie-Jesus Perez-Garcia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR1154504A priority Critical patent/FR2975595B1/fr
Publication of FR2975595A1 publication Critical patent/FR2975595A1/fr
Application granted granted Critical
Publication of FR2975595B1 publication Critical patent/FR2975595B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration
FR1154504A 2011-05-24 2011-05-24 Utilisation de la guanosine comme agent anti-irritant. Active FR2975595B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1154504A FR2975595B1 (fr) 2011-05-24 2011-05-24 Utilisation de la guanosine comme agent anti-irritant.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1154504A FR2975595B1 (fr) 2011-05-24 2011-05-24 Utilisation de la guanosine comme agent anti-irritant.

Publications (2)

Publication Number Publication Date
FR2975595A1 FR2975595A1 (fr) 2012-11-30
FR2975595B1 true FR2975595B1 (fr) 2013-08-02

Family

ID=44550336

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1154504A Active FR2975595B1 (fr) 2011-05-24 2011-05-24 Utilisation de la guanosine comme agent anti-irritant.

Country Status (1)

Country Link
FR (1) FR2975595B1 (fr)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE793306A (fr) * 1971-12-23 1973-04-16 Waldhof Aschaffenburg Papier Produit cosmetique
FR2620024B1 (fr) * 1987-09-09 1991-03-15 Dermatologiques Et Composition cosmetique comportant un agent antiradicaux libres, et agent correspondant
US20020006913A1 (en) * 1997-11-04 2002-01-17 Von Borstel Reid W. Antimutagenic compositions for treatment and prevention of photodamage to skin
US6531140B2 (en) * 1999-05-04 2003-03-11 E-L Management Anti-irritant compositions containing a cyclic nucleotide
DE10202251A1 (de) * 2002-01-21 2003-08-07 Beiersdorf Ag Kosmetische und/oder dermatologische Zubereitung
US7794739B2 (en) * 2002-04-09 2010-09-14 Otsuka Pharmaceutical Co., Ltd. Nucleic acid based composition for cell proliferation
FR2849377B1 (fr) * 2002-12-30 2007-08-03 Jean Noel Thorel Composition cosmetique, regulatrice de la flore cutanee
JP4249710B2 (ja) * 2002-12-30 2009-04-08 ジャン ノエル トレル、 皮膚代謝生理活性物質

Also Published As

Publication number Publication date
FR2975595A1 (fr) 2012-11-30

Similar Documents

Publication Publication Date Title
MX2016005574A (es) Composiciones de ribosido de nicotinamida para uso topico en el tratamiento de afecciones de la piel.
BR112015010772A2 (pt) composição de enxágue tópica, uso de uma composição e método para tratar ou melhorar a pele de um indivíduo contra a acne
EA201170876A1 (ru) Применение способной к вспениванию композиции, по существу, не содержащей фармацевтически активные ингредиенты, для лечения кожи человека
BRPI1106572B8 (pt) Composições que compreendem um retinoide e um inibidor de nfkb e seus métodos de uso
BRPI1001814B8 (pt) composição cosmética, uso cosmético de uma combinação, uso de pelo menos um lisado de pelo menos um microorganismo, e, método de tratamento cosmético
BR112015005339A8 (pt) uso de óleo de semente de fruta milagrosa como um ingrediente ativo
BR112016000335A8 (pt) método de tratamento da rosácea papulopustular, de tratamento de lesões inflamatórias da rosácea papulopustular e uso de uma composição farmacêutica
WO2011121250A3 (fr) Composition cosmetique et pharmaceutique comprenant de la n-acetyl-glucosamine- 6 - phosphate
BR112014006455A2 (pt) alquilamidotiazóis, preparações cosméticas ou dermatológicas com um teor de um ou vários alquilamidotiazóis e uso de um ou vários alquilamidotiazóis
EA201391592A1 (ru) Местная композиция для лечения гиперкератотической кожи
RU2014150505A (ru) Способ идентификации лигандов рецептора ahr, которые обладают терапевтической себосупрессивной активностью, и указанные лиганды
WO2012116990A3 (fr) Nouvelle utilisation
WO2012160289A3 (fr) Composition cosmétique comprenant un polymère superabsorbant et un glucide choisi parmi les oses, les oligosides et les homopolyholosides
WO2014008477A3 (fr) Activation du canal ionique trpv4 par stimuli physiques et rôle critique de trpv4 dans l'inflammation et la démangeaison spécifique à un organe
WO2017011356A3 (fr) Procédés et compositions pour traiter des maladies et des états induits par des médicaments
IN2014KN02914A (fr)
BR112015022044A2 (pt) um método de proporcionar neutroproteção ocular
RU2013158863A (ru) Ингибитор разложения гиалуроновой кислоты, включающий экстракт розмарина и ретинолацетата
MX353580B (es) Acido graso monoinsaturado para prevenir y/o tratar las imperfecciones del color de la piel.
MX2010006987A (es) Composiciones topicas que contienen destiobiotin y sus derivados y un metodo de tratamiento para la piel.
BR112012019868A2 (pt) composição farmacêutica para uso tópico
UA112418C2 (uk) Терапевтичний болезаспокійливий засіб
AR097216A1 (es) Composición para el tratamiento contra el envejecimiento de la piel
AR094035A1 (es) Estimulantes del colageno y su uso en el tratamiento de la piel
WO2014030117A3 (fr) Utilisation cosmétique de l'huile essentielle de laserpitium siler l. contre les signes de vieillissement de la peau et comme antioxydant

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13